94796 Items found

Search Products:

Enter Catalogue #, CAS # , Chemical Name or Mol Formula:

Advance Search

Search by Category


Search by Parent Drug
  • A100800
    A-1155463 Hydrochloride
    C₃₅H₃₂FN₅O₄S₂•HCl
    2-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-[4-[3-(dimethylamino)-1-propyn-1-yl]-2-fluorophenoxy]propyl]-4-thiazolecarboxylic Acid Hydrochloride;
  • A100803
    O-1821
    35482-50-9
    C₁₇H₂₂O₂
    5-Methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol;(1R-trans)-5-Methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; Cannabidiorcol; Cannabidiorocol
  • A100900
    A-1331852
    1430844-80-6
    C₃₈H₃₈N₆O₃S
    6-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]-2-pyridinecarboxylic Acid
  • A101010
    A350619 Hydrochloride
    1217201-17-6
    C₂₁H₂₆Cl₂N₂OS
    3-[2-[(4-Chlorophenyl)thio]phenyl]-N-[4-(dimethylamino)butyl]-2-propenamide, , Hydrochloride;
  • A101025
    A-366
    1527503-11-2
    C₁₉H₂₇N₃O₂
    5’-Methoxy-6’-[3-(1-pyrrolidinyl)propoxy]-spiro[cyclobutane-1,3’-[3H]indol]-2’-amine,
  • A101030
    A 37203
    220519-06-2
    C₂₀H₂₇F₃N₆OS
    Lu 201640; 2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(3H)-pyrimidinone; 2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(1H)-pyrimidinone
  • A101040
    A 419259 Trihydrochloride
    1435934-25-0
    C₂₉H₃₄N₆O•3HCl
    7-[trans-4-(4-Methyl-1-piperazinyl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Hydrochloride; A-419259 Trihydrochloride
  • A101042
    A 419259 Trihydrochloride-D3
    C₂₉H₃₁D₃N₆O•3HCl
    Trideuterated A 419259 Trihydrochloride
  • A101050
    A 54556B
    1629166-56-8
    C₃₇H₄₈N₆O₈
    A 54556 factor B; A 54556B; Antibiotic A 54556B; N-​[(2E,​4E,​6E)​-​1-​Oxo-​2,​4,​6-​octatrien-​1-​yl]​-​L-​phenylalanyl-​L-​seryl-​L-​prolyl-​N-​methyl-​L-​alanyl-​L-​alanyl-​L-​proline (6→2)​-​lactone
  • A101055
    A 54556A (~90%)
    95398-45-1
    C₃₈H₅₀N₆O₈
    (4R)-N-[(2E,4E,6E)-1-oxo-2,4,6-Octatrien-1-yl]-L-phenylalanyl-L-seryl-L-prolyl-N-methyl-L-alanyl-L-alanyl-4-methyl-L-proline (6→2)-lactone; A 54556 factor A; ADEP 1; Acyldepsipeptide 1; Acyldepsipeptide A; Antibiotic A 54556A
  • A101090
    A 61603
    107756-30-9
    C₁₅H₂₁BrN₂O₃S
    N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]methanesulfonamide Monohydrobromide; N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]methanesulfonamide Hydrobromide
  • A101100
    A66
    1166227-08-2
    C₁₇H₂₃N₅O₂S₂
    (2S)-N1-[2-(1,1-Dimethylethyl)-4’-methyl[4,5’-bithiazol]-2’-yl]-1,2-pyrrolidinedicarboxamide; (2S)-1-N-[5-(2-tert-Butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
  • A101200
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A101205
    A 769662
    844499-71-4
    C₂₀H₁₂N₂O₃S
    4-Hydroxy-3-(2’-hydroxy-1,1’-biphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile; 6,7-Dihydro-4-hydroxy-3-(2’-hydroxy[1,1’-biphenyl]-4-yl)-6-oxo-thieno[2,3-b]pyridine-5-carbonitrile
  • A101210
    A 83-01
    909910-43-6
    C₂₅H₁₉N₅S
    3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide
  • A101230
    A 844606
    861119-08-6
    C₂₀H₂₀N₂O₂
    2-(Hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl)-9H-xanthen-9-one; 2-(7-Methyl-3,7-diazabicyclo[3.3.0]octan-3-yl)xanthen-9-one;
  • A101250
    A-887826
    1266212-81-0
    C₂₆H₂₉ClN₄O₃
    5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-morpholinyl)-3-pyridinyl]methyl]-3-pyridinecarboxamide; A 887826;
  • A101252
    A-887826-d8
    1794753-88-0
    C₂₆H₂₁D₈ClN₄O₃
    5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-morpholinyl-d8)-3-pyridinyl]methyl]-3-pyridinecarboxamide; A 887826-d8;
  • A104490
    AAL-993
    269390-77-4
    C₂₀H₁₆F₃N₃O
    ZK260253; 2-​​[(4-​​Pyridinylmethyl)​amino]​-​​N-​​[3-​​(trifluoromethyl)​phenyl]​benzamide; 2-((Pyridin-4-ylmethyl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide
  • A104495
    AAEM Resin (Acetoacetoxyethyl Ketoester Resin)
    34500-18-0
    N/A
  • A104500
    AB-005
    895155-25-6
    C₂₃H₃₂N₂O
    [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
  • A104505
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • A104507
    AB-005 Azepane Isomer-D4
    C₂₃H₂₉D₃N₂O
    [1-(Hexahydro-1-methyl-1H-azepin-3-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone-D4
  • A104985
    Abacavir 5’-β-D-Glucuronide Sodium Salt
    C₂₀H₂₅N₆NaO₇
    [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl]methyl-β-D-Glucopyranosiduronic Acid Sodium Salt; Abacavir 5’-Glucuronide Sodium Salt
  • A104990
    Abacavir
    136470-78-5
    C₁₄H₁₈N₆O
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1S-cis)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; 1592U89; ABC; Abacavir API; Abacavir Impurities
  • A104995
    trans-Abacavir Dihydrochloride
    C₁₄H₂₀Cl₂N₆O
    (1R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Diydrochloride;
  • A104997
    trans-Abacavir-d4 Hydrochloride
    1346605-40-0
    C₁₄H₁₅D₄ClN₆O
    (1R,4R)-rel-4-[2-Amino-6-[cyclopropyl-d4)amino]-9H-purin-9-yl]-2-cyclopentene-1-methanol Hydrochloride; Abacavir Stable Isotope
  • A105000
    Abacavir Sulfate
    188062-50-2
    C₂₈H₃₈N₁₂O₆S
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Sulfate; Ziagen; Abacavir - In House Impurity; Abacavir Impurities; Abacavir Intermediates
  • A105002
    Abacavir-d4
    1217731-56-0
    C₁₄H₁₄D₄N₆O
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino-d4)-9H-purin-9-yl]-2-cyclopentene-1-methanol;(1S-cis)-4-[2-Amino-6-(cyclopropylamino-d4)-9H-purin-9-yl]-2-cyclopentene- 1-methanol; 1592U89-d4; ABC-d4; Abacavir Stable Isotope
  • A105005
    Abacavir Carboxylate
    384380-52-3
    C₁₄H₁₆N₆O₂
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-carboxylic Acid; 2269W; Abacavir - In House Impurity; Abacavir Impurities; Abacavir Metabolites
  • A105015
    ent-Abacavir
    136470-79-6
    C₁₄H₁₈N₆O
    (1R,4S)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1R-cis)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1R,4S)-Abacavir; Abacavir EP Impurity A; Abacavir Impurities
  • A105020
    Abacavir 5’-Phosphate
    136470-77-4
    C₁₄H₁₉N₆O₄P
    (1S,4R)- 4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Dihydrogen Phosphate (Ester); (1S-cis)-Abacavir Monophosphate; Abacavir - In House Impurity; Abacavir Impurities; Abacavir Metabolites
  • A105025
    rac-Abacavir Sulfate
    C₂₈H₃₈N₁₂O₆S
    Abacavir Sulfate Racemic; (4-[2-Amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol Sulfate (2:1);
  • A105030
    Abacavir 5’-(2,3,4-Tri-O-isobytyryl)-β-D-glucuronic Acid Methyl Ester
    C₃₃H₄₆N₆O₁₀
  • A105035
    Abacavir 5’-4-Chloro-6-methylpyrimidine-2,5-diamine
    1443421-69-9
    C₁₈H₂₁ClN₁₀O
    N6-Cyclopropyl-9-((1R,4S)-4-(((2,5-diamino-6-chloropyrimidin-4-yl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine; Abacavir USP Related Compound D; Abacavir EP Impurity B; ; Abacavir Impurities
  • A105037
    Abacavir-d4 5’-4-Chloro-6-methylpyrimidine-2,5-diamine
    C₁₈H₁₇D₄ClN₁₀O
    N6-Cyclopropyl-d4-9-((1R,4S)-4-(((2,5-diamino-6-chloropyrimidin-4-yl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine; Abacavir-d4 Related Compound D; Abacavir Stable Isotope
  • A105040
    Abacavir Triphosphate Trisodium Salt
    C₁₄H₁₈N₆Na₃O₁₀P₃
    P-[[(2S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl]methyl]ester Triphosphate Trisodium Salt
  • A105050
    AB-CHMICA
    C₂₁H₂₉N₃O₂
  • A105960
    AB-CHMINACA
    1185887-21-1
    C₂₀H₂₈N₄O₂
    N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide; (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
  • A105970
    AB-CHMINACA 2’-Indazole Isomer RM
    C₂₀H₂₈N₄O₂
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2H-indazole-3-carboxamide;
  • A105975
    AB-CHMINACA Metabolite M1A
    C₂₀H₂₈N₄O₃
    N-((S)-1-Amino-3-methyl-1-oxobutan-2-yl)-1-((3-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • A105980
    AB-CHMINACA Metabolite M1B
    C₂₀H₂₈N₄O₃
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • A105995
    AB-CHMINACA metabolite M2
    1185887-51-7
    C₂₀H₂₇N₃O₃
    N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-L-valine;
  • A106000
    AB-CHMINACA Metabolite M2 Methyl Ester
    1971007-96-1
    C₂₁H₃₁N₃O₃
    AMB N-Methylcyclohexyl Analog; Methyl [(1S)-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]-L-valinate
  • A106005
    AB-CHMINACA metabolite M3A
    C₂₀H₂₇N₃O₄
    (1-((4-Hydroxycyclohexyl)methyl)-1H-indazole-3-carbonyl)-L-valine;
  • A106009
    AB-CHMINACA metabolite M4-d4
    C₁₅H₁₄D₄N₂O₂
    1-(Cyclohexylmethyl)-1H-indazole-3-carboxylic-d4 Acid; AB-CHMINACA M4-d4;
  • A106010
    AB-CHMINACA metabolite M5A
    C₁₅H₁₈N₂O₃
    1-((4-hydroxycyclohexyl)methyl)-1H-indazole- 3-carboxylic Acid
  • A106025
    AB-CHMINACA metabolite M7
    C₂₀H₂₅N₃O₅
    2-(1-(Cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinic Acid
  • A106525
    ABP 688
    924298-51-1
    C₁₅H₁₆N₂O
    O-3-[2-(6-Methyl-2-pyridinyl)ethynyl]-methyloxime-2-cyclohexen-1-one;
  • A107000
    Abamectin >80% (contains up to 20% Avermectin B1b A107010)
    71751-41-2
    C₄₈H₇₂O₁₄
    Avermectin B1; MK-936; Agri-Mek; Avid; Zephyr;
  • A107005
    8,9-Z-Abamectin B1a
    113665-89-7
    C₄₈H₇₂O₁₄
    (8Z)-5-O-Demethylavermectin A1a; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran] Avermectin A1a Deriv.
  • A107010
    Abamectin B1b
    65195-56-4
    C₄₇H₇₀O₁₄
    5-O-Demethyl-25-de(1-methylpropyl)-25-(1-methylethyl)-avermectin A1a; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran] Avermectin A1a Derivative; Abamectin Component B1b; Antibiotic C 076B1b; Avermectin B1b;
  • A107200
    Abamine
    729612-64-0
    C₂₁H₂₄FNO₄
    N-[(2E)-3-(3,4-Dimethoxyphenyl)-2-propen-1-yl]-N-[(4-fluorophenyl)methyl]-glycine Methyl Ester; N-[(2E)-3-(3,4-Dimethoxyphenyl)-2-propenyl]-N-[(4-fluorophenyl)methyl]-glycine Methyl Ester
  • A107225
    Abarelix
    183552-38-7
    C₇₂H₉₅ClN₁₄O₁₄
    17: PN: WO2007012430 SEQID: 19 claimed protein; 1: PN: WO02056903 PAGE: 25 claimed protein; 5: PN: WO0018423 PAGE: 26 claimed protein; Abarelix; PPI 149; Plenaxis; R 3827; N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-D-alaninamide
  • A107228
    Abafungin
    129639-79-8
    C₂₁H₂₂N₄OS
    N-[4-[2-(2,4-Dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine; BAY-W 6341
  • A107250
    Abbvie Mcl-1 Inhibitor
    1668553-26-1
    C₄₆H₅₅N₇O₇S
    7-(5-((4-(4-(N,N-Dimethylsulfamoyl)piperazin-1-yl)phenoxy)methyl)-1,3-dimethyl-1H-pyrazol-4-yl)-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic Acid
  • A107600
    (+)-cis-Abienol
    17990-16-8
    C₂₀H₃₄O
    (1R,2R,4aS,8aS)-Decahydro-2,5,5,8a-tetramethyl-1-[(2Z)-3-methyl-2,4-pentadien-1-yl]-2-naphthalenol; [1R-[1α(Z),2β,4aβ,8aα]]-Decahydro-2,5,5,8a-tetramethyl-1-(3-methyl-2,4-pentadienyl)-2-naphthalenol; (1R,2R,4aS,8aS)-Decahydro-2,5,5,8a-tetramethyl-1-[(2Z)-3-methyl-2,4-pentadienyl]-2-naphthalenol; (Z)-Labda-12,14-dien-8-ol; (12Z)-Abienol; (Z)-Abienol; (8R)-cis-Labda-12,14-dien-8-ol, ; cis-Abienol; Δ12-cis-Abienol
  • A108190
    8,13(15)-Abietadienoic Acid
    19402-33-6
    C₂₀H₃₀O₂
    (1R,4aS,10aR)-1,2,3,4,4a,5,6,7,8,9,10,10a-Dodecahydro-1,4a-dimethyl-7-(1-methylethylidene)-1-Phenanthrenecarboxylic Acid; [1R-(1α,4aβ,10aα)]-1,2,3,4,4a,5,6,7,8,9,10,10a-Dodecahydro-1,4a-dimethyl-7-(1-methylethylidene)-1-phenanthrenecarboxylic Acid; 13-Isopropylidene-podocarp-8-en-15-oic Acid; Δ8,13(15)-Abietic Acid
  • A108200
    Abietic Acid, 75%
    514-10-3
    C₂₀H₃₀O₂
    (1R,4aR,4bR,10aR)-1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid; 13-Isopropylpodocarpa-7,13-dien-15-oic Acid; (-)-Abietic Acid; 7,13-Abietadien-18-oic Acid; Abietic Acid; NSC 25149; Odomit B 10; Sylvic Acid; ZAO; l-Abietic Acid;
  • A108205
    Abietic Acid Diamylamine
    881185-17-7
    C₂₀H₃₀O₂•C₉H₂₁N
    (1R,4aR,4bR,10aR)-1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid Compd. with N-Pentyl-1-pentanamine; (1R,4aR,4bR,10aR)- 1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid Compd. with N-Pentyl-1-pentanamine;
  • A108485
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • A108490
    Abiraterone
    154229-19-3
    C₂₄H₃₁NO
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; CB 7598;
  • A108492
    Abiraterone-d4
    C₂₄H₂₇D₄NO
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
  • A108495
    Abiraterone β-D-Glucuronide
    C₃₀H₃₉NO₇
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol β-D-Glucuronide;
  • A108500
    Abiraterone Acetate
    154229-18-2
    C₂₆H₃₃NO₂
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester); CB 7630;
  • A108502
    Abiraterone Acetate-d4
    C₂₆H₂₉D₄NO₂
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate-d4 (Ester); CB 7630-d4;
  • A108505
    Abiraterone Tosylate
    C₃₁H₃₇NO₃S
  • A108510
    Abiraterone Acetate N-Oxide
    C₂₆H₃₃NO₃
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester) N-Oxide; CB 7630 N-Oxide;
  • A108515
    Abiraterone Sulfate Sodium Salt
    C₂₄H₃₀NNaO₄S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Sulfate Sodium;
  • A108520
    Abiraterone N-Oxide Sulfate Sodium Salt
    C₂₄H₃₀NNaO₅S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol N-Oxide Sulfate Sodium Salt;
  • A108525
    Abiraterone Ethyl Ether
    C₂₆H₃₅NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108527
    Abiraterone Ethyl Ether-d5
    C₂₆H₃₀D₅NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy--d5-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108530
    Abiraterone Isopropyl Ether
    C₂₇H₃₇NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108532
    Abiraterone Isopropyl Ether-d7
    C₂₇H₃₀D₇NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-d7-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108535
    Abiaterone-5,6-epoxide
    C₂₄H₃₃NO₂
    5,6-Epoxy Abiaterone
  • A108540
    Abiraterone N-Oxide
    C₂₄H₃₁NO₂
  • A108545
    (3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
    186826-70-0
    C₄₃H₅₇NO₂
  • A108550
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
    186826-68-6
    C₄₇H₆₁NO₄
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol Acetate (ester)
  • A108555
    3,5-cyclo-Abiraterone
    C₂₄H₃₁NO
  • A108910
    Abnormal Cannabidiol
    22972-55-0
    C₂₁H₃₀O₂
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
  • A108912
    Abnormal Cannabidiol-d9
    C₂₁H₂₁D₉O₂
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol-d9; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9
  • A108980
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • A109000
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A109002
    AB-PINACA-d9
    C₁₈H₁₇D₉N₄O₂
    (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(pentyl-2,2’,3,3’,4,4’,5,5,5-d9)-1H-indazole-3-carboxamide
  • A109005
    AB-PINACA N-(5-Hydroxypentyl) Metabolite
    C₁₈H₂₆N₄O₃
    N-(1-Amino-3-methyl-1-oxobutn-2-yl)-1-(5-hydroxypentyl)-1H-indazole-3-carboxamide
  • A109095
    Abscisic Acid Methyl Ester
    60102-39-8
    C₁₆H₂₂O₄
    (+)-Methyl Abscisate; (S)-Abscisic Acid Methyl Ester; 5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester
  • A110000
    (+)-cis,trans-Abscisic Acid, 98%
    21293-29-8
    C₁₅H₂₀O₄
    (S-(Z,E)])-5-(1-Hydroxy-2,6,6-trimethyl)-4-oxo-2-cyclohexen-1-yl-3-methyl-2,4-pentadienoic Acid; (+)-(S)-Abscisic Acid; (+)-(cis,trans)-Abscisic Acid; (+)-ABA; S-ABA; Dormin;
  • A110002
    (+)-cis,trans-Abscisic Acid-d6
    721948-65-8
    C₁₅H₁₄D₆O₄
    [S-(Z,E)]-5-[1-Hydroxy-6,6-dimethyl-2-(methyl-d6)-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; S-ABA-d6; Dormin-d6;
  • A110003
    (+)-cis,trans-Abscisic Acid-d6
    35671-08-0
    C₁₅H₁₄D₆O₄
    (S-(Z,E)])-5-(1-Hydroxy-2,6,6-trimethyl)-4-oxo-2-cyclohexen-1-yl-3-methyl-2,4-pentadienoic Acid-d6; (+)-(S)-Abscisic Acid-d6; (+)-(cis,trans)-Abscisic Acid-d6; (+)-ABA-d6; S-ABA-d6; Dormin-d6;
  • A110005
    (+)-Abscisic Aldehyde
    41944-86-9
    C₁₅H₂₀O₃
    (2Z,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienal; (+)-Abscisyl aldehyde; Abscisic Aldehyde
  • A110010
    rac 8’-Acetylene Abscisic Acid Methyl Ester
    192987-96-5
    C₁₇H₂₀O₄
    (2Z,4E)-rel-5-[(1R,6R)-6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid Methyl Ester; PBI 429;
  • A110015
    (±)-Abscisic Aldehyde
    29448-38-2
    C₁₅H₂₀O₃
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal; PBI 37
  • A110017
    (±)-Abscisic Aldehyde-d3
    C₁₅H₁₇D₃O₃
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal-d3; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal-d3; PBI 37-d3;
  • A110020
    (±)-cis,trans-Abscisic Acid
    14375-45-2
    C₁₅H₂₀O₄
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (RS)-Abscisic Acid; (±)-(cis,trans)-Abscisic Acid; (±)-2-cis-4-trans-Abscisic Acid; (±)-ABA; (±)-Abscisic Acid; PBI 57; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (Z,E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid
  • A110025
    (+)-trans,trans-Abscisic Acid
    6755-41-5
    C₁₅H₂₀O₄
    (2E,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; (+)-trans-Abscisic Acid; (E,E)-Abscisic Acid; 2-trans,4-trans-Abscisic Acid; E,E-(+)-Abscisic Acid; trans-trans-(+)-Abscisic Acid; S-ttABA; [S-(E,E)]-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (E,E)-(S)-(+)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (2E,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid
  • A110030
    (±)-cis,trans-Abscisic Acid Methyl Ester
    6901-96-8
    C₁₆H₂₂O₄
    ABAMe; (±)-Abscisic Acid Methyl Ester; (±)-Methyl Abscisate; (±)-cis-Abscisin Methyl Ester; Methyl Abscisate; PBI 0; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester; (Z,E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester; (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester
  • A110035
    (±)-cis,trans-Abscisic Acid Glucosyl Ester
    79199-48-7
    C₂₁H₃₀O₉
    ABAGlc; (Z,E)-1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; (±)-Abscisic Acid Glucose Ester; (Z,E)-(±)-1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; 1-[(2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose
  • A110040
    (±)-cis,trans-Abscisic Acid-ß-D-glucopyranosyl Ester Tetraacetate
    79199-47-6
    C₂₉H₃₈O₁₃
    (Z,E)-(±)-2,3,4,6-Tetraacetate 1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; (Z,E)-2,3,4,6-Tetraacetate 1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; ABAGlcTAc
  • A110045
    (+)-cis,trans-Abscisic Acid-L-glutamic Acid
    1285592-12-2
    C₂₀H₂₇NO₇
    ABA-L-Glu; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-glutamic Acid; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-glutamic Acid
  • A110050
    (+)-cis,trans-Abscisic Acid-L-phenylalanine
    1285591-91-4
    C₂₄H₂₉NO₅
    N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-phenylalanine; ABA-L-Phe; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-phenylalanine
94796 Items found
Translate »